You have 9 free searches left this month | for more free features.

boceprevir

Showing 1 - 25 of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hepatitis C, Chronic Trial (Boceprevir, Peginterferon alfa-2b (PEG2b), Ribavirin (RBV))

Completed
  • Hepatitis C, Chronic
  • Boceprevir
  • +3 more
  • (no location specified)
Jan 15, 2021

Chronic Hepatitis C Genotype 1 Trial (Boceprevir, Placebo, peginterferon alfa-2b)

Completed
  • Chronic Hepatitis C Genotype 1
  • Boceprevir
  • +3 more
  • (no location specified)
Jan 15, 2021

Against HCV Based on Direct-acting Antivirals in Real-life

Completed
  • Chronic Hepatitis C Infection
  • Seville, Andalusia, Spain
    Valme University Hospital
Jun 22, 2022

Hepatitis C, Chronic Trial (Boceprevir)

Terminated
  • Hepatitis C, Chronic
  • Boceprevir
  • (no location specified)
Aug 13, 2018

Hepatitis C Trial (boceprevir, PegIFN-2b, RBV)

Completed
  • Hepatitis C
  • boceprevir
  • +2 more
  • (no location specified)
Aug 6, 2018

Thrombocytopaenia Trial in Baltimore (Eltrombopag, Boceprevir, Telaprevir)

Completed
  • Thrombocytopaenia
  • Baltimore, Maryland
    GSK Investigational Site
Nov 8, 2017

Hepatitis C Trial (boceprevir)

Completed
  • Hepatitis C
  • boceprevir
  • (no location specified)
Mar 9, 2017

Hepatitis C, Chronic, Cirrhosis Trial in Cleveland (Telaprevir, Boceprevir, Peg-IFN)

Completed
  • Hepatitis C, Chronic
  • Cirrhosis
  • Cleveland, Ohio
    Louis Stokes Cleveland VA medical center
Mar 13, 2017

Hepatitis C, Chronic, HIV Trial in Vienna (Pegylated interferon alpha-2a, Ribavirin, Boceprevir)

Completed
  • Hepatitis C, Chronic
  • HIV
  • Pegylated interferon alpha-2a
  • +2 more
  • Vienna, Austria
    Division of Gastroenterology and Hepatology, Department of Inter
Feb 8, 2017

Hepatitis C Trial (boceprevir, PegIFN-2b, RBV)

Withdrawn
  • Hepatitis C
  • boceprevir
  • +2 more
  • (no location specified)
Mar 17, 2017

Hepatitis C Trial in Beverly Hills, Baltimore (Alisporivir, Boceprevir, Peginterferon alfa-2a)

Terminated
  • Hepatitis C
  • Beverly Hills, California
  • +1 more
Nov 18, 2016

Triple Combination Therapy With Boceprevir, Peginterferon

Terminated
  • Hepatitis C, Chronic
  • Boceprevir
  • +3 more
  • Budapest, Hungary
  • +6 more
Oct 18, 2016

HCV Infection, Liver Cirrhosis, Experimental Trial in France (Boceprevir, Peg-Interferon a-2b or Peg-Interferon a-2a, Ribavirin)

Completed
  • HCV Infection
  • Liver Cirrhosis, Experimental
  • Boceprevir
  • +2 more
  • Bordeaux, France
  • +18 more
Jan 23, 2017

Hepatitis C, Chronic Trial in Worldwide (boceprevir, peginterferon alfa-2a [Pegasys], ribavirin (Copegus])

Completed
  • Hepatitis C, Chronic
  • boceprevir
  • +2 more
  • Graz, Austria
  • +31 more
Nov 1, 2016

Hepatitis C, Chronic Trial in Worldwide (Copegus, Pegasys, boceprevir)

Completed
  • Hepatitis C, Chronic
  • Littleton, Colorado
  • +23 more
Aug 3, 2016

Hepatitis C, Human Immunodeficiency Virus Trial in Netherlands (Boceprevir)

Completed
  • Hepatitis C
  • Human Immunodeficiency Virus
  • Boceprevir
  • Rotterdam, Zuid Holland, Netherlands
  • +8 more
Mar 2, 2016

Dual And Triple Therapies Based on Peginterferon Alfa in Chronic

Completed
  • Hepatitis C, Chronic
  • Peg-IFN Alfa-2a
  • +4 more
  • Antwerpen, Belgium
  • +271 more
Feb 10, 2017

Hepatitis C Trial in Calgary (Boceprevir)

Completed
  • Hepatitis C
  • Boceprevir
  • Calgary, Alberta, Canada
    University of Calgary Liver Unit
Aug 22, 2015

Hepatitis C Infection, End Stage Renal Disease Trial (P-IFN alfa 2a, P-IFN alfa 2b, Ribavirin)

Withdrawn
  • Hepatitis C Infection
  • End Stage Renal Disease
  • P-IFN alfa 2a
  • +3 more
  • (no location specified)
Sep 21, 2015

Treating Hispanic Patients Diagnosed With Hepatitis C Using

Terminated
  • Hepatitis C Infection
  • Boceprevir
  • Riverside, California
    Southern California Transplantation Institute Research Foundatio
Jun 27, 2015

Hepatitis, HIV/AIDS Trial in Washington, DC, Bethesda (Boceprevir, Peg-Interferon-alfa 2B, Ribavirin)

Terminated
  • Hepatitis
  • HIV/AIDS
  • Boceprevir
  • +2 more
  • Washington, DC, District of Columbia
  • +1 more
Jul 9, 2015

Hepatitis C, HIV, COINFECTION Trial in Barcelona (boceprevir, Ribavirin, Peginterferon alfa-2a)

Completed
  • Hepatitis C
  • +2 more
  • boceprevir
  • +3 more
  • Barcelona, Spain
    Hospital Clinic i Provincial de Barcelona
Jul 8, 2015

Genotype 4 Chronic Hepatitis C Infection Trial in Giza (Boceprevir, Peginterferon alfa-2b, ribavirin)

Unknown status
  • Genotype 4 Chronic Hepatitis C Infection
  • Boceprevir
  • +2 more
  • Giza, Egypt
    Theodor Bilharz Research Institute
Dec 25, 2014

Hepatitis C Trial in London (Boceprevir, St John's Wort)

Completed
  • Hepatitis C
  • Boceprevir
  • St John's Wort
  • London, United Kingdom
    St Stephen's AIDS Trust
Sep 23, 2014

Effect of Boceprevir on HCV-specific T Cell Responses

Completed
  • Chronic Hepatitis C
  • Boceprevir
  • Parma, Italy
    Unit of Infectious Diseases and Hepatology
Nov 5, 2013